Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Intra-operative Pancreatoscopy in Patients With IPMN

NCT: NCT03729453 · ACTIVE_NOT_RECRUITING

NCT IDNCT03729453
StatusACTIVE_NOT_RECRUITING
Start Date2019-03-20
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

To demonstrate the added value of intraoperative pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant pancreas; to generate a hypothesis for a subsequent randomized control trial.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑